Creabilis Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $150M

Creabilis General Information

Description

Developer of pharmaceuticals for treatment of dermatological and inflammatory diseases. The company's lead product, CT327, is a topical treatment for chronic pruritus. It intents to build a pruritus franchise around the CT327 and CT340 candidates which were developed using the company's proprietary Low Systemic Exposure (LSE) platform technology.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6 Denne Hill Business Centre
  • Womenswold
  • Canterbury CT4 6HD
  • England, United Kingdom
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 6 Denne Hill Business Centre
  • Womenswold
  • Canterbury CT4 6HD
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Creabilis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 06-Dec-2016 $150M Completed Generating Revenue
5. Debt - General 01-Sep-2015 Completed Generating Revenue
4. Debt - General 01-Jul-2014 Completed Generating Revenue
3. Grant 05-Nov-2012 Completed Startup
2. Later Stage VC (Series B) 04-Oct-2011 $20M $51.2M Completed Startup
1. Early Stage VC (Series A) 05-Jun-2008 $31.2M $31.2M Completed Startup
To view Creabilis’s complete valuation and funding history, request access »

Creabilis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceuticals for treatment of dermatological and inflammatory diseases. The company's lead product, CT32
Drug Discovery
Canterbury, United Kingdom
9 As of 2015

Wayne, PA
 

Princeton, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Creabilis Competitors (13)

One of Creabilis’s 13 competitors is Aclaris Therapeutics, a Formerly VC-backed company based in Wayne, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aclaris Therapeutics Formerly VC-backed Wayne, PA
Bristol-Myers Squibb Corporation Princeton, NJ
Biocon Biologics Formerly PE-Backed Bengaluru, India
Samsung Bioepis Corporate Backed or Acquired Incheon, South Korea
Gilead Formerly VC-backed Foster City, CA
You’re viewing 5 of 13 competitors. Get the full list »

Creabilis Patents

Creabilis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014177510-A2 Polymer conjugates of indolocarbazole compounds in the treatment of pruritus Inactive 03-May-2013
WO-2014177510-A3 Polymer conjugates of indolocarbazole compounds in the treatment of pruritus Inactive 03-May-2013
WO-2011003870-A2 Mini-pegylated corticosteroids, compositions including same, and methods of making and using same Inactive 06-Jul-2009
WO-2011003870-A3 Mini-pegylated corticosteroids, compositions including same, and methods of making and using same Inactive 06-Jul-2009
AU-2009331490-A1 Synthesis of polymer conjugates of indolocarbazole compounds Active 22-Dec-2008 A61K47/60
To view Creabilis’s complete patent history, request access »

Creabilis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Creabilis Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
AbbVie Ventures Corporate Venture Capital Minority
Kreos Capital Lender/Debt Provider Minority
NeoMed Management Venture Capital Minority
Sofinnova Partners Venture Capital Minority
To view Creabilis’s complete investors history, request access »

Creabilis Investments (2)

Creabilis’s most recent deal was a Later Stage VC with Nautilus Biotech for . The deal was made on 30-Apr-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nautilus Biotech 30-Apr-2007 Later Stage VC Biotechnology
Nautilus Biotech 01-Mar-2005 Later Stage VC Biotechnology
To view Creabilis’s complete investments history, request access »

Creabilis FAQs

  • When was Creabilis founded?

    Creabilis was founded in 2003.

  • Where is Creabilis headquartered?

    Creabilis is headquartered in Canterbury, United Kingdom.

  • What is the size of Creabilis?

    Creabilis has 9 total employees.

  • What industry is Creabilis in?

    Creabilis’s primary industry is Drug Discovery.

  • Is Creabilis a private or public company?

    Creabilis is a Private company.

  • What is the current valuation of Creabilis?

    The current valuation of Creabilis is .

  • What is Creabilis’s current revenue?

    The current revenue for Creabilis is .

  • How much funding has Creabilis raised over time?

    Creabilis has raised $51.2M.

  • Who are Creabilis’s investors?

    AbbVie Ventures, Kreos Capital, NeoMed Management, and Sofinnova Partners have invested in Creabilis.

  • Who are Creabilis’s competitors?

    Aclaris Therapeutics, Bristol-Myers Squibb, Biocon Biologics, Samsung Bioepis, and Gilead are some of the 13 competitors of Creabilis.

  • When was Creabilis acquired?

    Creabilis was acquired on 06-Dec-2016.

  • Who acquired Creabilis?

    Creabilis was acquired by Sienna Biopharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process